Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw

NCT03418454 is registered in ClinicalTrials.gov with Barzilai Medical Center as lead sponsor.

NCT NCT03418454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw
Lead sponsor
Barzilai Medical Center
Phase
Observational
Overall status
Unknown status
Start date
December 14, 2017
Completion date
December 31, 2021
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medication related osteonecrosis of the jaw, oral epithelial dysplasia, oral squamous cell carcinoma